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Summary The influence of extensive intraductal component (EIC) on local recurrence risk was studied for
496 patients with stage I-II infiltrating ductal cancers treated by conservative surgery and irradiation. EIC
was diagnosed in 65 of 231 (28%) premenopausal and 41 of 265 (15.5%) post-menopausal patients. Local
recurrence risk was markedly increased in EIC+ patients (5-year actuarial risk 18% versus 8% without EIC,
P<0.001), but this effect appeared limited to premenopausal patients. Local recurrence risk increased with
increasing degree of EIC. EIC with more than 50% intraductal carcinoma was more prevalent in patients
younger than 40, perhaps accounting to some degree for the higher local recurrence rates observed in younger
patients. The presence of EIC had no influence on overall survival, on median time to local recurrence, or on
short-term survival after local failure. The usefulness of EIC as a risk factor for local recurrence is discussed.
Extensive intraductal component (EIC), as defined by Schnitt
et al. (1984), is said to be present when 25% or more of an
invasive breast cancer consists of intraductal carcinoma, and
ductal carcinoma in situ (DCIS) is also present outside the
main tumour mass. Available evidence indicates that the
presence of EIC correlates positively with the quantity of
residual cancer remaining in the breast after conservative
excision (Schnitt et al., 1987; Holland et al., 1990), and
clinical studies from Harvard University suggest that
tumours with EIC have a high risk of recurring in the breast,
despite adequate radiotherapy (Recht et al., 1986).
Although EIC has been viewed with scepticism by some
authors (Fisher et al., 1986; Calle et al., 1986), it not clear
whether or not an effort had been made by other inves-
tigators to reproduce the definitions used by the Harvard
group. Evaluation of the clinical significance of EIC was one
of the goals of a retrospective clinico-pathological study of
the risk factors for local recurrence carried out at the Cancer
Institute in Marseille, the overall results of which will appear
elsewhere (Kurtz et al., 1990). The purpose of the current
paper is to examine more closely the potential influence of
EIC on local recurrence risk, with a detailed comparison of
our results with those of the Harvard group. In addition, the
question of the age dependence of EIC will be addressed, as
well as the possible influence of EIC on overall survival, time
interval to recurrence, and survival after recurrence.
Patients and methods
The study group consisted of 496 evaluable patients with
clinical stages T-TT (American Joint Committee, 1983)
infiltrating ductal carcinomas who had breast-conserving
surgery at the Cancer Institute in Marseille between January
1975 and December 1983. This formed the major part of a
study including 587 cancers of all histological subtypes
(Kurtz et al., 1989). Briefly, primary treatment consisted of
wide excision of the primary tumour, including dissection of
the lower two axillary levels in 487 patients. Radiotherapy
delivered 50 Gy in 5 weeks to the breast and regional nodes
on telecobalt, or its equivalent on telecesium, followed by
supplemental irradiation of 20-25 Gy to the tumour bed
using an electron beam. Selected patients also received
adjuvant hormonal or chemotherapy with various agents.
Histological slides of all primary tumours were reviewed
without prior knowledgeJof the treatment outcome. The 496
cases classified as infiltrating ductal carcinomas also included
all cases of tubular carcinoma (World Health Organization,
1982), atypical medullary carcinoma (Rapin et al., 1988), as
well as invasive ductal carcinomas with predominant int-
raductal component (World Health Organization, 1982). The
amount of intraductal cancer within the primary tumour was
estimated as less than 25%, 25-50% or more than 50%, and
outside the tumour mass as being either absent or present, as
suggested by Schnitt et al. (1984). EIC was diagnosed when
25% or more of the tumour consisted of DCIS and DCIS
was also present in the periphery.
Resection margins were reviewed retrospectively, using sec-
tions taken through the tumour, as well as separate sections
from the periphery. Although the surgeon had performed
what was considered a macroscopically complete excision, no
intra-operative frozen section control of resection margins
had been carried out, and the specimens had not been
marked with India ink. In some cases, therefore, a confident
assessment of microscopic resection margins could not be
made, especially when peripheral sections were unavailable
for review; in such instances, margins were classified as
indeterminate.
Actuarial calculations were performed according to
methods described by Kaplan and Meier (1958). Local recur-
rence included recurrent cancer in the parenchyma or skin of
the treated breast, regardless of prior events. Overall survival
included deaths from all causes. Differences between actuarial
curves were tested for significance by the log rank test, and
differences between proportions by the x2 test (Peto et al.,
1977).
Results
Correlation ofEIC with local recurrence risk
After a median follow-up of 71 months, recurrent cancer in
the treated breast was observed in 61 of 496 (12%) patients.
Local failure was very significantly associated with both the
degree of DCIS within the primary tumour and the presence
of intraductal cancer in its periphery (Table I). Local recur-
rence occurred in 22 of 114 (19%) tumours containing 25%
or more DCIS, compared with 39 of 382 (10%) with lesser
amounts (P<0.01). Similarly, failure in the breast was
observed in 41 of 269 (15%) of tumours with DCIS in their
periphery, compared with only 20 of 227 (9%) in tumours
having no demonstrable intraductal cancer in breast tissue
outside the invasive lesion (P<0.05). However, in only eight
instances was extensive DCIS diagnosed within the tumour
without some degree of intraductal carcinoma being
identified in the periphery, and in none of these was a local
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recurrence observed. It is apparent from Table I that the high
local recurrence risk is associated with the subgroup demons-
trating both adverse features, corresponding to the definition
of EIC proposed by the Harvard group (Boyages et al.,
1989). The 5-year actuarial local failure rate for tumours with
and without EIC are 18% and 8%, respectively (P<0.001).
The corresponding computer-generated curves for actuarial
risk of local breast recurrence are shown in Figure 1 for each
of the two groups.
Correlation ofEIC with type oflocal recurrence
Compared with 390 patients without EIC, the 106 EIC +
patients had an increased incidence of operable failure near
the primary tumour bed (16 of 106, 15%, versus 18 or 390,
4.6%, P<0.001), whereas there was no difference in the
incidence of either operable recurrence elsewhere in the
breast (3 of 106, 2.8%, versus 12 of 390, 3.1%) or of
inoperable recurrence (3 of 106, 2.8%, versus 9 of 390,
2.3%).
Importance ofthe degree ofEIC
The influence of the degree of EIC on local recurrence was
investigated. EIC + patients with more than 50% DCIS had
significantly more local recurrences than those with 25-50%
DCIS (Table IT), whereas the local failure rate in the latter
group was only slightly higher than in the EIC- group.
Influence ofEIC on survival
Acturarial overall survival from time of initial therapy is
shown in Figure 2 for both EIC + and EIC - patients.
Despite the marked differences in local recurrence between
the two groups, the survival curves were identical, with a
10-year survival of 72% in each case.
Table I Dependence of local recurrence in the treated breast on the
extent of intraductal cancer within the primary tumour and on the
presence or absence of intraductal cancer outside the infiltrating
tumour
Crude breast recurrence rate
DCIS adjacent to tumour
DCIS within tumour Present Absent
25% or more 22/106 (21%) 0/8 (0%)
Less than 25% 19/163 (12%) 20/219 (9%)
The subgroup with extensive intraductal component (EIC) is in
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Figure 1 Actuarial probability of local recurrence in the treated
breast, according to the presence or absence of extensive int-
raductal component (EIC). The numbers below the time axis
indicate the number of breasts at risk for each interval.
Table II Dependence ofcrude local recurrence rate on the degree of
intraductal component
Crude breast recurrence rate
EIC- 39/390 (10%) p<0.001
EIC + 22/106 (21%)
with 25-50% DICS 10/70 (14%) P<0.05
with >50% DCIS 12/36 (33%)
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Figure 2 Actuarial overall survival following initial treatment,
according to the presence or absence of extensive intraductal
component (EIC). The numbers below the time axis indicate the
number of patients at risk for each interval. n.s. = not significant.
Relation ofEIC to resection margins
Retrospective review of resection margins indicated that
EIC + patients more commonly had inadequate excision (24
of 106, 23%) than did EIC- patients (25 of 390, 6.5%,
P<0.001). However, in the presence of EIC, local recurrence
rate was high, regardless of whether resection margins were
negative (5 of 27, 18.5%), positive (7 of 24, 29.2%) or
indeterminate (10 of 55, 18.2%).
Correlation ofage with EIC
EIC was found more frequently in premenopausal (65 of 321,
28%) than in post-menopausal patients (41 of 265, 15.5%
P<0.05). The age distribution according to the degree of
EIC is shown in Table ITT. The prevalence of EIC is similar
in both older age groups. The higher frequency of EIC in
younger patients reflects a significantly greater prevalence of
25-50% DCIS in patients age 40-49 and of the extreme
form of EIC (more than 50% DCIS) in patients younger
than 40.
Table III Dependence of the degree of extensive intraductal
component on patient age for 496 patients with infiltrating ductal
carcinomas
Prevalence (%)
Age (n) >50% DCIS 25-50% DCIS Total EIC +
<40 (62) 11 (18%) 7 (11%) 18 (29%)
40-49 (147) 11 (8%) 33 (22%) 44 (30%)
50-59 (161) 9 (6%) 18 (11%) 27 (17%)
>60 (126) 5 (4%) 12 (9d/%) 17 (13%)
P 0.001 0.001 0.025
The italicised values in each column are significantly different from
those not italicised (X2 test). DCIS = intraductal carcinoma within
primary tumour.
I I I ,I1
p < 0.001
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The influence of EIC on local recurrence risk according to
menopausal status is presented in Table IV. The importance
of EIC as a risk factor appears confined to premenopausal
patients. Post-menopausal patients with EIC have an iden-
tical local failure rate to patients without EIC. For EIC +
patients, the difference in local failure rate between pre- and
post-menopausal patients was of borderline statistical
significance (P<0.09).
Influence ofEIC on the course ofrecurrent patients
For 22 EIC + patients and 39 EIC- patients suffering local
failure, both the median time interval between initial treat-
ment and local recurrence and the short-term survival after
recurrence were similar for both groups. Local failure for
EIC + patients occurred after a median interval of 29
months (range 11 -1 18 months), for EIC- cases after a
median interval of 29.5 months (range 8-98 months). Three-
year overall survival after local failure was 51.4% for EIC +
and 55.5% for EIC- patients (median follow-up after failure
26 months).
Discussion
The current study confirms that the presence of EIC cor-
relates significantly with the probability of local recurrence
after conservative surgery and radiotherapy. However, this
analysis points out certain characteristics which may limit the
degree of usefulness of EIC as a risk factor, perhaps explain-
ing why its importance has not been uniformly recognised by
other groups examining more limited case material (Fisher et
al., 1986; Calle et al., 1986). These problematic aspects in-
clude the reproducibility of the diagnosis of EIC, the possible
interactions of EIC with resection margins in determining
risk, and the effect of age both on the incidence of EIC and
the probability of local recurrence.
Studies of re-excision after previous biopsy (Schnitt et al.,
1987) as well as of serial subgross sectioning of whole breast
specimens following simulated tumorectomy (Holland et al.,
1990) strongly suggest that EIC is an important marker of
residual cancer after local tumour resection. Based on these
data, the Harvard group has advanced the hypothesis that
extensive residual intraductal cancer in the vicinity of the
excised primary lesion is responsible for the high local failure
rate associated with EIC (Boyages et al., 1989). A direct
assessment of the quantity of DCIS outside the primary
tumour mass would most likely provide the best marker for
residual intraductal cancer beyond the margins of excision,
but the rim of macroscopically normal breast tissue available
for pathological examination is generally too narrow to allow
a consistently reliable evaluation of this sort. Apparently the
extent of DCIS within the tumour provides a valid indirect
measure of residual cancer, provided that DCIS can in fact
be documented in the periphery as well (Table T).
Overall, our results correspond rather closely to those of
the Harvard group, with 5-year actuarial local failure rates
with and without EIC of 18% versus 8% for the Marseille
patients and 25% versus 5% for the Boston patients. How-
ever, whereas the majority of local failures (36 of 53, 68%) in
the patients reported by Boyages et al. (1989) were associated
with EIC, only 22 of the 61 recurrences in our series could be
attributed to this risk factor. Thus, significantly more recur-
Table IV Influence ofextensive intraductal component (EIC) on local
recurrence in the breast for 496 infiltrating ductal cancers, according to
menopausal status
Crude breast recurrence rate
Premenopausal (n
= 231)
EIC + 17/65 (26%) P<0 001 EIC- 13/166(8%)
Post-menopausal (n
= 265)
EIC+ 5/41 (12%) P>0.8 EIC- 26/224 (12%)
rences were noted in the Marseille than in the Boston series
for patients having less than 25% DCIS within the tumour
(39 of 382, or 10.2% versus 16 of 279, or 5.7%, P<0.01). In
this sense, our data support, at least to a limited extent, the
clinical usefulness of the concept of EIC as defined by Schnitt
et al. (1987) but suggest that other explanations should be
sought for the substantial number of local failures not
accounted for by this single risk factor. In addition, we have
shown that the extreme form of EIC, with more than 50%
DCIS within the tumour, appears to be associated with a
particularly high risk of local relapse (Table TT). As in the
Boston series, EIC predicts uniquely for a higher likelihood
of operable recurrence in the vicinity of the primary tumour,
while the risk of recurrence elsewhere in the breast or of
inoperable recurrence seem unaffected by EIC.
It is interesting to note that the diagnosis of EIC was made
significantly less often in our series than in the Boston
patients (106 of 496, 21%, versus 143 of 445, 32%,
P<0.001). This may reflect a true difference in the prevalence
of EIC between breast cancer patients in Massachusetts and
those in the south of France, or may be related to differences
in age distribution. It is likely, however, that our ability to
diagnose EIC had been hindered to some degree by the
relatively small number of histological sections available for
review in this study (mean number 4.1). In addition, the
semiquantitative assessment required to diagnose EIC is
likely to be carried out in a somewhat different manner from
pathologist to pathologist, despite attempts to utilise identical
criteria. The difficulties associated with the use of mor-
phological features as risk factors have been discussed by
other authors (Gilchrist et al., 1985).
Considering the evidence correlating EIC with residual
tumour burden, it is not surprising that resection margins in
EIC + patients appear less commonly to be adequate. The
confounding of EIC and resection margin status as com-
peting risk factors has been alluded to by the Harvard group
(Recht et al., 1986). The exclusion of the 10% of patients
having positive margins from breast-conserving therapy may
account for the failure of the pathologists of the National
Surgical Adjuvant Breast Project to identify EIC as a risk
factor for local failure (Fisher et al., 1986). Harris et al.
(1985) have proposed a strategy of re-excision in patients
with EIC, in the hopes of reducing local recurrence rates by
achieving more generous margins. Our retrospective analysis
of resection margins, however, suggests that local recurrence
risk may be inherently high for EIC + patients, despite
apparently adequate excision. This merits more careful pro-
spective evaluation.
The most important finding of our study was the notion
that EIC may have limited importance as a risk factor in
post-menopausal patients. We found that EIC is distinctly
more prevalent in patients younger than 50, and that the
extreme form of EIC is seen predominantly in women
younger than 40 (Table ITT). The latter correlation may be at
least partially responsible for the higher breast recurrence
risk observed in this young age group (Calle et al., 1986;
Recht et al., 1988; Kurtz et al., 1988). An association
between extent of intraductal component and young age has
been noted previously by us (Jacquemier et al., 1985) as well
as by other authors (Fisher et al., 1975; Recht et al., 1988;
Migliori, 1982).
Moreover, our data suggest that ETC is not only less
prevalent in older patients, but that its presence has little
influence on local recurrence risk after the menopause (Table
IV). Similarly, Bartelink et al. (1988) found a positive
association between 25% or more DCIS and local recurrence
for patients younger than 50, but none for older patients . In
addition, the Harvard data show no influence of EIC for
patients older than 65, but suggest that this feature is predic-
tive of local failure for the age groups less than 35, 35-50
and 51-65. These observations raise the possibility that the
reliability of EIC as a marker of residual cancer decreases
with increasing age, or that residual tumour responds
differently to treatment as a function of age.
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did not appear to have any other prognostic significance in
our series. There was no significant difference in overall
survival between patients with or without EIC (Figure 2), a
similar observation having been made by Boyages et al.
(1989). Additionally, as far as could be judged by rather
limited follow-up, the clinical behaviour of local recurrences
in both groups of patients appeared to be similar, in that
both the median time to local failure and short-term survival
after relapse were the same for EIC + and EIC- patients.
In summary, our analysis confirms the Harvard data, as
well as the subsequent studies of Bartelink et al. (1988),
Lindley et al. (1989) and Fourquet et al. (1989), demons-
trating a significant association between EIC and the risk of
failure in the breast after limited tumour excision and
radiotherapy. However, the usefulness of EIC as a risk factor
may be limited particularly by the age dependence of this
feature. It is possible that EIC reflects a form of local tumour
growth which depends on high circulating estrogen levels for
its propagation, and that this feature becomes both less
common and biologically less significant in post-menopausal
patients.
In contrast to the earliest reports (Schnitt et al., 1984), it is
now apparent that local failure is observed in substantial
numbers of conservatively treated patients whose tumours
had not demonstrated EIC, so that recurrence risk cannot be
adequately assessed by this single factor. Given the increasing
popularity of breast-conserving treatment, continued clinical
investigation in this area is certainly justified. The relative
importance of EIC and resection margins as competing
markers of residual tumour burden should be evaluated pro-
spectively. For a given tumour burden, moreover, the risk of
local failure after potentially curative radiotherapy may also
depend upon histopathologic characteristics of the primary
lesion, making it likely that other factors in addition to EIC
and resection margins will prove to be important. Examples
of features identified thus far include histologic grade (Lind-
ley et al., 1989; Kurtz et al., 1990), prominent lymphocytic
stromal resection (Lindley et al., 1989; Kurtz et al., 199t0,
tumour necrosis (Lindley et al., 1989) and vascular invasion
(Fisher et al., 1986; Fourquet et al., 1989). Assessment of the
relative value of these morphological features, as well as of
various biological measures of tumour aggressiveness, will
require additional study.
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